Zurich Cantonal Bank
BEAM icon

Zurich Cantonal Bank’s Beam Therapeutics BEAM Stock Holding History

Zurich Cantonal Bank’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Sell
99,526
-2,603
-3% -$78.6K 0.01% 863
2026
Q1 		$2.43M Buy
102,129
+58,348
+133% +$1.62M 0.01% 928
2025
Q4 		$1.21M Buy
43,781
+6,354
+17% +$162K ﹤0.01% 1236
2025
Q3 		$908K Buy
37,427
+4,893
+15% +$97.3K ﹤0.01% 1346
2025
Q2 		$553K Buy
32,534
+6,597
+25% +$115K ﹤0.01% 1596
2025
Q1 		$507K Buy
25,937
+3,308
+15% +$86.7K ﹤0.01% 1591
2024
Q4 		$561K Buy
22,629
+1,233
+6% +$31.5K ﹤0.01% 1562
2024
Q3 		$524K Buy
21,396
+516
+2% +$13.3K ﹤0.01% 1530
2024
Q2 		$489K Sell
20,880
-221
-1% -$5.43K ﹤0.01% 1503
2024
Q1 		$697K Buy
21,101
+376
+2% +$11.7K ﹤0.01% 1270
2023
Q4 		$564K Buy
20,725
+8,818
+74% +$219K ﹤0.01% 1424
2023
Q3 		$286K Buy
11,907
+1,549
+15% +$41.5K ﹤0.01% 1732
2023
Q2 		$331K Buy
10,358
+86
+0.8% +$2.79K ﹤0.01% 1613
2023
Q1 		$315K Buy
10,272
+750
+8% +$29.6K ﹤0.01% 1590
2022
Q4 		$372K Sell
9,522
-79
-0.8% -$3.54K ﹤0.01% 1424
2022
Q3 		$457K Sell
9,601
-1,038
-10% -$59.2K ﹤0.01% 1251
2022
Q2 		$412K Buy
10,639
+1,043
+11% +$41.5K ﹤0.01% 1346
2022
Q1 		$550K Buy
9,596
+380
+4% +$24.9K ﹤0.01% 1286
2021
Q4 		$734K Buy
9,216
+1,353
+17% +$116K ﹤0.01% 1189
2021
Q3 		$684K Buy
7,863
+630
+9% +$63.3K ﹤0.01% 1100
2021
Q2 		$931K Buy
7,233
+1,552
+27% +$124K 0.01% 917
2021
Q1 		$455K Buy
5,681
+3,523
+163% +$335K ﹤0.01% 1290
2020
Q4 		$176K Buy
+2,158
New +$106K ﹤0.01% 1929

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Zurich Cantonal Bank's BEAM Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Beam Therapeutics (BEAM) stake by 2.5% in Q2 2026, selling an estimated $78.6K and leaving 99,526 shares worth $3.42M. The position accounts for 0.01% of the portfolio, ranked #863.

Zurich Cantonal Bank first reported a position in BEAM in Q4 2020 and has held it in 23 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Zurich Cantonal Bank held 99,526 shares of Beam Therapeutics worth $3.42M as of Q2 2026.
  • Zurich Cantonal Bank sold 2,603 Beam Therapeutics shares in Q2 2026, an estimated $78.6K.
  • Beam Therapeutics made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #863 holding.
  • Zurich Cantonal Bank first reported a position in Beam Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.